Latest news
Foundation for Angelman Syndrome Therapeutics Announces Agreement with Apertura Gene Therapy for Access to Blood-Brain Barrier-Crossing Capsid - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTKwality Pharmaceuticals hosts Q1FY27 earnings call on Aug 10 - scanx.tradescanx.trade · Tue, 04 Aug 2026 15:28:38 GMTTSC Alliance and Apertura Gene Therapy Complete Preclinical Pilot Study Evaluating AAV Gene Therapy Approach Designed for TSC1 - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT